448
Views
13
CrossRef citations to date
0
Altmetric
Article

Antifungal activity of essential oil-encapsulated lipid nanoemulsions formulations against leaf spot disease on tomato caused by Alternaria alternata

ORCID Icon, &
Pages 235-257 | Received 30 Aug 2021, Accepted 20 Nov 2021, Published online: 14 Dec 2021
 

ABSTRACT

This study aimed to find out the optimal formulation of essential oil-encapsulated lipid nanoemulsions (EO-LNs) by comparing antifungal activity against leaf spot disease caused by Alternaria alternata on tomato plants of 10 different EO-LNs, followed by their binary and ternary combinations. Firstly, 10 EO-LNs and their combined formulations were prepared and their in-vitro antifungal activity was evaluated using petri dish bioassay. Next, ex-vitro disease-prevention and disease-treatment experiments of the optimal EO-LNs formulation were carried out in the greenhouse. The results indicated that there was a significant difference in in-vitro antifungal activity against Alternaria alternata among 10 EO-LNs and their combined formulations. Overall, NaChiGarCin (the ternary combination of chili oil-encapsulated LNs, garlic oil-encapsulated LNs, cinnamon oil-encapsulated LNs) exhibited the highest in-vitro antifungal activity. Under ex-vitro condition, NaChiGarCin at an EO-concentration of 200 ppm showed the highest disease-preventing and treating effectiveness (above 80%) and showed no negative effect on the plant growth.

Supplemental data for this article is available online at http://dx.doi.org/10.1080/03235408.2021.2015887 .

Disclosure statement

No potential conflict of interest was reported by the authors.

Funding

This study was partly supported by Institute of Developmental Philosophy (Vietnam) and Nuclear Research Institute (Vietnam).

Authors’ contributions

MHN contributed to the conception, design of the article. The experiments were carried out by MHN, NBDV and TNMT. Data curation and analysis were done by MHN. Writing and revising the entire manuscript was done by MHN, NBDV and TNMT. The authors have read, revised and approved the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.